Actively Recruiting
MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy
Led by University of Chicago · Updated on 2026-04-27
180
Participants Needed
1
Research Sites
157 weeks
Total Duration
On this page
Sponsors
U
University of Chicago
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Doctors leading this study hope to learn about a software that researchers at the University of Chicago have developed to help analyze radiographic images (different techniques for taking images that allow doctors to visualize the body's internal structures) of the prostate. Participation in this research will last about 12 months. There is a one-time MRI and 1-2 biopsies and then the investigator would like to follow the participant's progress.
CONDITIONS
Official Title
MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with known or suspected prostate cancer referred for diagnostic prostate MRI followed by MRI-guided fusion biopsy
- Voluntary written informed consent before the MRI exam
You will not qualify if you...
- Unable to provide informed written consent
- Unable to follow study protocols or communicate with researchers
- Psychiatric disorders affecting ability to consent
- Prisoners
- Under 18 years old
- Previous treatments for prostate cancer such as surgery, radiation, focal ablation, hormone or chemotherapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Chicago Medicine Comprehensive Cancer Center
Chicago, Illinois, United States, 60637
Actively Recruiting
Research Team
A
Aytekin Oto, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SCREENING
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here